Primera página del artículo de sobre bronquiectasias. THEODORE WILLIAMS, C. la fisiopatología de las bronquiectasias. El conocimiento acerca de. RESUMO: As bronquiectasias, outrora frequentes, têm vindo a tomarse numa situação patológia comparativamente rara. No entanto, a sua importância clínica . Las bronquiectasias no asociadas a fibrosis quística son una enfermedad compleja que ha despertado cada vez más interés científico debido a su creciente.
|Published (Last):||17 March 2013|
|PDF File Size:||3.1 Mb|
|ePub File Size:||1.96 Mb|
|Price:||Free* [*Free Regsitration Required]|
Effect of sputum bacteriology on the quality of bronquiectasis of patients with bronchiectasis. Chest physiotherapy techniques in bronchiectasis.
Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.
Bronquiectasias | Blausen Medical
Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with noncystic fibrosis bronchiectasis. Socioeconomic deprivation, readmissions, mortality bornquiectasias acute exacerbations of bronchiectasis.
Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Polymicrobial airway bacterial communities in adult bronchiectasis patients. Goyal V, Chang AB. Cochrane Database Syst Rev. Recent Advances and Continuing Challenges. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Microbiologic follow-up study in adult bronchiectasis. Inhaled hyperosmolar agents for bronchiectasis.
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: An international derivation and validation study.
A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Mortality in non-cystic fibrosis bronchiectasis: Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Ann Am Thorac Soc. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: Bronchiectasis in fe diverse US population.
State of the art review: Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial.
Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.
Chang AB, Bilton D. Assessing response to treatment of exacerbations of bronchiectasis in adults. British Thoracic Society guideline for non-CF bronchiectasis.
Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.
Controlled trial of ceftazidime vs. Systemic comorbidities in bronchiectasis. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: Pathological findings of bronchiectases caused by ycobacterium avium intracellulare complex.
Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Servicio de ayuda de la revista. Multidimensional approach to non-cystic fibrosis bronchiectasis: The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis.
Bronchiectasis-associated hospitalizations in Germany, British Thoracic Society Research Committee.
There was a problem providing the content you requested
Kellett F, Robert NM. Exacerbations in cystic fibrosis: Inhaled steroids for bronchiectasis. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
Trace Elements and Host Defense: A prospective cohort analysis. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis.
Symptoms of airway reflux predict exacerbations and fisiopaotlogia of life in bronchiectasis. Bilateral bronchiectasis and bronchiolitis at thin-section CT: Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
The bronchiectasis severity index. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.